Baseline circulating irisin levels are significantly and positively correlated with BMI, metabolic syndrome components, and insulin resistance; this supports the concept that higher irisin levels are associated with increase in body weight, which is also associated with an increase in WAT [4,32]. Here, FNDC5 is linked to metabolic syndrome.